ABOUT OUR LAST CC, my positive thoughts:

"it may not be immediately apparent, we have made immense progress..."
"the further development of a phase2b/3 NASH trial protocol..."
" a preclinical NASH study for identifying a NASH partner..."
"a longer acting molecule related to HIV..."
"a partnership with a AI - company..."
" a new communication strategy..."
"the lawsuit against Amarex with the possibility of obtaining a LIMITED damage compensation..."
"FDA action against Amarex..."
"substantial progress in the hold resubmission-FDA asks feedback from HIV patient advocates and Key Opinion Leaders-FDA wants to indentify the ideal MDR population-preparing a clinical HIV trial..."
"narrowing down to the single most sub population HIV-resubmitting our response to the FDA in September..."
"a stellar turnout for the advisory board HIV MDR meeting..."
"filing a phase2b/3 Nash trial protocol subsequent to the FDA hold submission..."


So, not bad at all....if our molecule works and i think IMO it does... we will be at the finish line sooner our later
GLTA